FFA
MRTX

Founders Financial Alliance’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Founders Financial Alliance’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17
Closed -$4K – 1315
2020
Q3 		$4K Buy
+17
New +$2.33K ﹤0.01% 1100

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Founders Financial Alliance's MRTX Position: Q4 2020 in Review

Founders Financial Alliance sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2020, closing a stake of 17 shares — an estimated $4K sold.

Founders Financial Alliance first reported a position in MRTX in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 284 funds tracked by Wall St. Rank hold MRTX as of Q4 2020.

  • Founders Financial Alliance reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 17 Mirati Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $4K.
  • Founders Financial Alliance first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's Mirati Therapeutics, Inc. Common Stock position peaked at $4K in Q3 2020.
  • 284 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.